BackLiminatus Pharma Warrants Overview

Liminatus Pharma Warrants Current Cash

Track Liminatus Pharma Warrants's current cash ($270K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$272672.00
↓ 72.73% YoYΔ $-727076.00 vs prior year quarter

Peer average

Loading

Liminatus Pharma Warrants Current Cash History

Loading

Liminatus Pharma Warrants vs. peers: Current Cash Comparison

Loading

Liminatus Pharma Warrants Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Liminatus Pharma Warrants (LIMNW) FAQ

The latest current cash for LIMNW is $270K as of March 2022. That compares with $1M in the prior-year period — down 72.7% year over year. Investors often review this figure alongside Liminatus Pharma Warrants's historical trend and sector peers before judging valuation or financial health.

Over the past year, LIMNW's current cash moved from $1M to $270K — a 72.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Liminatus Pharma Warrants's operating scale or balance-sheet position.

A current cash figure of $270K for LIMNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting LIMNW's current cash ($270K), review year-over-year change from $1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.